Karine Spiegel1, Esra Tasali, Rachel Leproult, Neal Scherberg, Eve Van Cauter. 1. Institut National de la Santé et de la Recherche Médicale/Université Claude Bernard Lyon-Unité 628, Physiologie Intégrée du Système d'Éveil, Université Claude Bernard Lyon 1, 8 Avenue Rockefeller, 69373 Lyon Cedex 08, France. karine.spiegel@univ-lyon1.fr
Abstract
CONTEXT: The acylation of ghrelin is essential for its stimulatory effects on GH release and appetite. Most of the physiology of ghrelin has been defined based on the assay of total ghrelin (TG), which mainly reflects levels of unacylated ghrelin. Whether levels of acylated ghrelin (AG) are influenced by circadian time and sleep and impact glucose regulation under physiologic conditions is not known. METHODS: Blood was sampled at 10- to 30-min intervals for 24 h in 14 healthy young lean men under controlled conditions of activity, light-dark cycle, and sleep-wake schedule. The subjects ingested three identical carbohydrate-rich meals at 5-h intervals. Sleep was polygraphically monitored. Levels of TG and AG were measured by RIA. The 24-h profiles of glucose and insulin levels were assessed simultaneously. RESULTS: Postprandial glucose concentrations were positively correlated with mean levels of AG but not TG, independently of insulin. Postprandial suppression and rebound of AG and TG occurred in parallel and were not impacted by time of day. The nocturnal elevation of AG and TG reflects the postdinner rebound curbed by an inhibitory effect of sleep. The ratio of AG to TG was lower during sleep than during wake, consistent with a reduction of orexigenic signal. CONCLUSIONS: Individual differences in AG levels may be an important predictor of overall glucose control under physiological conditions. Sleep, but not time of day, impacts postprandial TG and AG responses. The inhibitory effect of sleep on ghrelin release and acylation is consistent with the association between sleeping and fasting.
CONTEXT: The acylation of ghrelin is essential for its stimulatory effects on GH release and appetite. Most of the physiology of ghrelin has been defined based on the assay of total ghrelin (TG), which mainly reflects levels of unacylated ghrelin. Whether levels of acylated ghrelin (AG) are influenced by circadian time and sleep and impact glucose regulation under physiologic conditions is not known. METHODS: Blood was sampled at 10- to 30-min intervals for 24 h in 14 healthy young lean men under controlled conditions of activity, light-dark cycle, and sleep-wake schedule. The subjects ingested three identical carbohydrate-rich meals at 5-h intervals. Sleep was polygraphically monitored. Levels of TG and AG were measured by RIA. The 24-h profiles of glucose and insulin levels were assessed simultaneously. RESULTS: Postprandial glucose concentrations were positively correlated with mean levels of AG but not TG, independently of insulin. Postprandial suppression and rebound of AG and TG occurred in parallel and were not impacted by time of day. The nocturnal elevation of AG and TG reflects the postdinner rebound curbed by an inhibitory effect of sleep. The ratio of AG to TG was lower during sleep than during wake, consistent with a reduction of orexigenic signal. CONCLUSIONS: Individual differences in AG levels may be an important predictor of overall glucose control under physiological conditions. Sleep, but not time of day, impacts postprandial TG and AG responses. The inhibitory effect of sleep on ghrelin release and acylation is consistent with the association between sleeping and fasting.
Authors: Holly S Callahan; David E Cummings; Margaret S Pepe; Patricia A Breen; Colleen C Matthys; David S Weigle Journal: J Clin Endocrinol Metab Date: 2004-03 Impact factor: 5.958
Authors: J C Weikel; A Wichniak; M Ising; H Brunner; E Friess; K Held; S Mathias; D A Schmid; M Uhr; A Steiger Journal: Am J Physiol Endocrinol Metab Date: 2002-10-15 Impact factor: 4.310
Authors: Jenny Tong; Ronald L Prigeon; Harold W Davis; Martin Bidlingmaier; Steven E Kahn; David E Cummings; Matthias H Tschöp; David D'Alessio Journal: Diabetes Date: 2010-06-28 Impact factor: 9.461
Authors: P Lucidi; G Murdolo; C Di Loreto; N Parlanti; A De Cicco; A Ranchelli; C Fatone; C Taglioni; C Fanelli; F Santeusanio; P De Feo Journal: J Endocrinol Invest Date: 2004-05 Impact factor: 4.256
Authors: Andrea Dzaja; Mira A Dalal; Hubertus Himmerich; Manfred Uhr; Thomas Pollmächer; Andreas Schuld Journal: Am J Physiol Endocrinol Metab Date: 2004-02-10 Impact factor: 4.310
Authors: D E Cummings; R Scott Frayo; Corinne Marmonier; Roberte Aubert; Didier Chapelot Journal: Am J Physiol Endocrinol Metab Date: 2004-03-23 Impact factor: 4.310
Authors: E C Hanlon; E Tasali; R Leproult; K L Stuhr; E Doncheck; H de Wit; C J Hillard; E Van Cauter Journal: J Clin Endocrinol Metab Date: 2015-01 Impact factor: 5.958
Authors: Stephanie Feudjio Feupe; Patrick F Frias; Sara C Mednick; Elizabeth A McDevitt; Nathaniel D Heintzman Journal: J Diabetes Sci Technol Date: 2013-09-01
Authors: Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary Journal: Physiol Rev Date: 2017-01 Impact factor: 37.312
Authors: Erin C Hanlon; Esra Tasali; Rachel Leproult; Kara L Stuhr; Elizabeth Doncheck; Harriet de Wit; Cecilia J Hillard; Eve Van Cauter Journal: Sleep Date: 2016-03-01 Impact factor: 5.849